Track the American Oncology Network, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 18 July 2024 (Attribution). Among the most active insiders: Divers Stephen. The full history is accessible without an account.
20
Insider Decl.
n/a
Thresholds
€16,833
2 ops.
Buy Volume
€2m
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate American Oncology Network, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
46Σ signal
Buys €16,833€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,271 of 29,053 companies
17.3
score / 100
Value
23
Quality
12
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn·
Net mgn-7.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
25,000 shares0Class A Common StockSEC:0001104659-23-102499:0
20 of 20 declarations
About American Oncology Network, Inc.
American Oncology Network, Inc. is a company specializing in the provision of oncology care services. It primarily operates in the United States and focuses on improving outcomes for cancer patients.